Atherosclerotic vascular disease and diabetes in the older adult part II

Rationale and strategies for multi-interventional treatment

Jennifer Wheaton, Sally M. Pinkstaff

Research output: Contribution to journalArticle

Abstract

Given that diabetes-related atherosclerotic vascular disease is the leading cause of death in older patients with diabetes, aggressive treatment of multiple risk factors is the name of the game. A timely, multi-interventional approach can reduce risk as early as 6 months. Explaining an "A through E" strategy to patients may improve patient participation, with greater numbers of patients achieving treatment goals in a shorter period of time. Use of an "A through E" handout can reinforce, the importance of multiple therapies. In summary, the evidence is clear. Older patients with diabetes benefit tremendously from CVD risk reduction. It is our responsibility to avoid clinical inertia and to find ways to implement these guidelines into our day-to-day practice.

Original languageEnglish (US)
Pages (from-to)25-35
Number of pages11
JournalClinical Geriatrics
Volume14
Issue number2
StatePublished - Feb 2006

Fingerprint

Vascular Diseases
Patient Participation
Risk Reduction Behavior
Therapeutics
Names
Cause of Death
Guidelines

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Atherosclerotic vascular disease and diabetes in the older adult part II : Rationale and strategies for multi-interventional treatment. / Wheaton, Jennifer; Pinkstaff, Sally M.

In: Clinical Geriatrics, Vol. 14, No. 2, 02.2006, p. 25-35.

Research output: Contribution to journalArticle

@article{012e5891d65f4c378f43d67fbf44c534,
title = "Atherosclerotic vascular disease and diabetes in the older adult part II: Rationale and strategies for multi-interventional treatment",
abstract = "Given that diabetes-related atherosclerotic vascular disease is the leading cause of death in older patients with diabetes, aggressive treatment of multiple risk factors is the name of the game. A timely, multi-interventional approach can reduce risk as early as 6 months. Explaining an {"}A through E{"} strategy to patients may improve patient participation, with greater numbers of patients achieving treatment goals in a shorter period of time. Use of an {"}A through E{"} handout can reinforce, the importance of multiple therapies. In summary, the evidence is clear. Older patients with diabetes benefit tremendously from CVD risk reduction. It is our responsibility to avoid clinical inertia and to find ways to implement these guidelines into our day-to-day practice.",
author = "Jennifer Wheaton and Pinkstaff, {Sally M.}",
year = "2006",
month = "2",
language = "English (US)",
volume = "14",
pages = "25--35",
journal = "Clinical Geriatrics",
issn = "1095-1598",
publisher = "HMP Communications LLP",
number = "2",

}

TY - JOUR

T1 - Atherosclerotic vascular disease and diabetes in the older adult part II

T2 - Rationale and strategies for multi-interventional treatment

AU - Wheaton, Jennifer

AU - Pinkstaff, Sally M.

PY - 2006/2

Y1 - 2006/2

N2 - Given that diabetes-related atherosclerotic vascular disease is the leading cause of death in older patients with diabetes, aggressive treatment of multiple risk factors is the name of the game. A timely, multi-interventional approach can reduce risk as early as 6 months. Explaining an "A through E" strategy to patients may improve patient participation, with greater numbers of patients achieving treatment goals in a shorter period of time. Use of an "A through E" handout can reinforce, the importance of multiple therapies. In summary, the evidence is clear. Older patients with diabetes benefit tremendously from CVD risk reduction. It is our responsibility to avoid clinical inertia and to find ways to implement these guidelines into our day-to-day practice.

AB - Given that diabetes-related atherosclerotic vascular disease is the leading cause of death in older patients with diabetes, aggressive treatment of multiple risk factors is the name of the game. A timely, multi-interventional approach can reduce risk as early as 6 months. Explaining an "A through E" strategy to patients may improve patient participation, with greater numbers of patients achieving treatment goals in a shorter period of time. Use of an "A through E" handout can reinforce, the importance of multiple therapies. In summary, the evidence is clear. Older patients with diabetes benefit tremendously from CVD risk reduction. It is our responsibility to avoid clinical inertia and to find ways to implement these guidelines into our day-to-day practice.

UR - http://www.scopus.com/inward/record.url?scp=33644639749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644639749&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 25

EP - 35

JO - Clinical Geriatrics

JF - Clinical Geriatrics

SN - 1095-1598

IS - 2

ER -